Paul F Dellaripa
Overview
Explore the profile of Paul F Dellaripa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McDermott G, Gill R, Byrne S, Gagne S, Wang X, Paudel M, et al.
medRxiv
. 2025 Feb;
PMID: 39974108
Background: Risk factors and screening strategies for rheumatoid arthritis-associated interstitial lung disease (RA-ILD) have received limited evaluation in patients with early RA. We investigated RA-ILD prevalence, risk factors, and the...
2.
Bae S, Abtin F, Kim G, Markovic D, Chan C, Moghadam-Kia S, et al.
RMD Open
. 2024 Nov;
10(4).
PMID: 39608864
Objectives: To explore the association between the extent of CT abnormalities by quantitative imaging analysis (QIA) and clinical/physiological disease parameters in patients with antisynthetase syndrome associated interstitial lung disease (ARS-ILD)....
3.
McDermott G, Hayashi K, Juge P, Gill R, Byrne S, Gagne S, et al.
Arthritis Care Res (Hoboken)
. 2024 Sep;
77(2):185-194.
PMID: 39257341
Objective: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) includes multiple subtypes with varying histopathology, prognosis, and potential treatments. Limited research has investigated risk factors for different RA-ILD subtypes. Therefore, we examined...
4.
Santacroce L, Yang S, Summit R, Valle A, Collins J, Dellaripa P, et al.
Arthritis Care Res (Hoboken)
. 2024 Sep;
77(1):116-126.
PMID: 39245945
Objective: Environmental hazards and heightened neighborhood social vulnerability coexist and disproportionately affect minoritized populations. We investigated associations between exposure to adverse environmental burden concentrated in areas with high social vulnerability...
5.
Bae S, Markovic D, Saygin D, Sullivan D, Yamaguchi K, Moghadam-Kia S, et al.
Rheumatology (Oxford)
. 2024 Sep;
PMID: 39222437
Objective: The 6-min walk test (6MWT) is a simple test widely used to assess sub-maximal exercise capacity in chronic respiratory diseases. We explored the relationship of 6-min walk distance (6MWD)...
6.
Tukpah A, Rose J, Seger D, Dellaripa P, Hunninghake G, Bates D
Rheumatology (Oxford)
. 2024 Aug;
PMID: 39120917
Objective: Racial and ethnic differences in presentation and outcomes have been reported in systemic sclerosis (SSc) and SSc-interstitial lung disease (ILD). However, prior studies have limited diversity. We aim to...
7.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Rheumatol
. 2024 Jul;
76(8):1182-1200.
PMID: 38978310
Objective: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). Methods: We developed clinically relevant population, intervention, comparator, and...
8.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Care Res (Hoboken)
. 2024 Jul;
76(8):1051-1069.
PMID: 38973731
Objective: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). Methods: We developed clinically relevant population, intervention, comparator, and...
9.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Care Res (Hoboken)
. 2024 Jul;
76(8):1070-1082.
PMID: 38973729
Objective: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic...
10.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Rheumatol
. 2024 Jul;
76(8):1201-1213.
PMID: 38973714
Objective: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic...